First fill abandonment rates—which can be as high as 30%—create gaps in the desired treatment plan between patients and providers. Clearly, there is a huge opportunity to improve the new-to-brand experience and potentially improve outcomes over the long term.
Based on fresh market research from our own provider communities as well as industry data, our new whitepaper takes a look at the opportunities that life sciences companies have to address common new-to-brand patient challenges while building positive brand awareness.
Understand the market dynamics contributing to new-to-brand engagement strategies
Uncover opportunities to remove the barriers to new prescription trial through a combination of technology integration, improved supply chain management, and timely, relevant patient support
Learn how patient and provider engagement can be leveraged to address new-to-brand challenges
© 2016 Aptus Health. All rights reserved.
100% Privacy Guaranteed.
Request Whitepaper Now